Joseph Jenrette to Combined Modality Therapy
This is a "connection" page, showing publications Joseph Jenrette has written about Combined Modality Therapy.
Connection Strength
0.252
-
High-dose radiotherapy to 78 Gy with or without temozolomide for high grade gliomas. J Neurooncol. 2009 Jul; 93(3):343-8.
Score: 0.068
-
Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy. Brachytherapy. 2008 Oct-Dec; 7(4):305-9.
Score: 0.066
-
The role of radiotherapy in the management of resected uterine papillary serous and clear cell carcinoma. Eur J Obstet Gynecol Reprod Biol. 2008 Dec; 141(2):163-8.
Score: 0.066
-
A Phase II study of anti-epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme. J Neurosurg. 2010 Aug; 113(2):192-8.
Score: 0.019
-
Successful treatment of late, recurrent wilms tumor with high-dose chemotherapy and autologous stem cell rescue in third complete response. J Pediatr Hematol Oncol. 2010 Aug; 32(6):e241-3.
Score: 0.019
-
Survival with combined modality therapy after intracerebral recurrence of pleuropulmonary blastoma. Med Pediatr Oncol. 1998 Jan; 30(1):63-6.
Score: 0.008
-
Combined modality therapy in the treatment of epidermoid carcinoma of the anus at the Medical University of South Carolina. J S C Med Assoc. 1993 Jul; 89(7):333-6.
Score: 0.006